Lewisville, TXNCT06566716Now EnrollingIRB Ready

Ovarian Neoplasms Clinical Trial in Lewisville, TX

Access cutting-edge ovarian neoplasms treatment through this clinical trial at a research site in Lewisville. Study-provided care at no cost to qualified participants.

Sponsored by Cleo Diagnostics Ltd

Quick Self-Assessment

See if you qualify for this Lewisville location

Preparing your pre-screening questions…

Expert Care in Lewisville

Access ovarian neoplasms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ovarian neoplasms treatment provided free

Apply for This Lewisville Location

Check if you qualify for this ovarian neoplasms clinical trial in Lewisville, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lewisville

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lewisville site if eligible
  4. 4Begin participation

About This Ovarian Neoplasms Study in Lewisville

Ovarian cancer is a serious health risk with the highest death rate among gynecological cancers. Unfortunately, it's only possible to definitively diagnose ovarian cancer after surgery, as there are no reliable tests to determine if an ovarian abnormality is cancerous or benign before surgery. Cleo Diagnostics have developed a new test that uses five biomarkers in the blood to better differentiate between benign and malignant ovarian conditions. In initial studies, this test outperformed the current standard test, CA125, in identifying cancer. This study aims to evaluate the effectiveness of the Cleo Diagnostics (CleoDX) Ovarian Adnexal Mass Score Test System. This test measures five analytes in the blood and provides a score indicating the likelihood of cancer in patients with an adnexal mass requiring surgery. The test is designed to assist doctors in making better-informed decisions about surgery and patient care by providing a more accurate pre-surgical assessment of cancer risk. By doing so, it aims to improve patient outcomes and ensure that those with malignant conditions receive the appropriate specialist care.

Sponsor: Cleo Diagnostics Ltd

Who Can Participate

Inclusion Criteria

female patients =\> 18 years of age at the time of consent
Can provide written informed consent
Have an ovarian cyst or adnexal mass (simple, complex, or solid ovarian/pelvic mass) identified through imaging examination (e.g. transvaginal ultrasound - TVU) that requires surgery, but have not yet undergone this surgery

Exclusion Criteria

Any prior confirmed diagnosis of, or treatment for, ovarian cancer
Any prior surgery resulting in removal of both ovaries
Prior history of gynecological malignancy (within last 2 years)
Prior history of melanoma (within last 2 years)
Prior treatment (within 12 months of sample collection) with chemotherapy, radiotherapy or immunotherapy
Immune-compromised. Definition: those whose weakened immune system may render them more susceptible to infection, illness, or complications. These may include patients with immune-suppressive conditions (e.g. HIV/AIDS), patients undergoing immuno-, chemo- or radio-therapy (within the last 12 months) for any reason, receiving immune suppressive therapies (e.g. transplant recipients, individuals with known autoimmune disease), or with a primary immunodeficiency disorder (e.g. Lupus).
Pregnant currently or within the last 3 months based on participant self-report

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lewisville?

Yes, this clinical trial (NCT06566716) has an active research site in Lewisville, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ovarian Neoplasms Treatment Options in Lewisville, TX

If you're searching for ovarian neoplasms treatment options in Lewisville, TX, this clinical trial (NCT06566716) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lewisville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian neoplasms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ovarian neoplasms clinical trials near you to find additional studies recruiting in your area.

More Ovarian Cancer Trials in Lewisville, TX

See all ovarian cancer clinical trials recruiting in Lewisville — not just this study.

Browse Ovarian Cancer Trials in Lewisville

Ready to Join in Lewisville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lewisville, TX